Uncertainty remains around outcomes on the FCA’s delayed motor finance review into banned commission arrangements. Are there risks to auto ABS investors?
A delayed verdict: the FCA’s motor finance review, a risk to UK auto ABS?
Credit Risk Monitor – Q2 2024
Jim Cielinski, Global Head of Fixed Income, discusses the sharp rise in rates and the very gradual deterioration in the credit cycle.
U.S. corporate credit: Are valuations cheaper than they look?
Looking into the U.S. investment-grade corporate credit market and the present level of credit spreads.
Bond markets: Time to get active and defensive portfolios into shape
Jay Sivapalan, Head of Australian Fixed Interest, discusses the current state of bond markets and provides insights on recent market volatility which has the potential to drive significant returns for investors if navigated correctly.
Quick view: Tech stocks sell-off driven by exuberance for AI, not fundamentals
Recent volatility in tech stocks was mainly driven by other factors and not stock fundamentals. Opportunities emerge for active managers when there are price dislocations.
Quick view: Navigating market volatility
With investors reacting to the worst global stock market sell-off since 2020, we consider the all-important question – what next?
Biotech sector update: Going for gold
Amid interest rate cuts and accelerating innovation, the biotechnology sector could be set up for strong performance.
Get Britain building again: housing associations key to delivery of Labour’s promise
Labour’s promise to deliver 1.5m homes over five years is set to boost housing associations, but dispersion within the sector is set to increase.
Market leaves Fed behind
Moves in bond yields suggest Fed is behind the curve.
Global Perspectives: Navigating insurance portfolio management
In this episode, Head of Australian Fixed Interest, Jay Sivapalan, and Matthew Bullock, EMEA Head of Portfolio Construction and Strategy, explore the complex field of insurance portfolio management, highlighting the distinct challenges, opportunities, and the critical role of regulatory compliance in shaping investment approaches for Insurers.